Spot and Stop Common Errors With GLP-1 Agonists

February 2026

You’ll be challenged to avoid errors when dispensing GLP-1 agonists (semaglutide, etc)...for weight loss, diabetes, and other conditions.

Product selection. Review the indications for each GLP-1 agonist and watch for mix-ups, since the same med might be sold under different brands and used for different conditions.

For example, Ozempic (semaglutide), Mounjaro (tirzepatide), and Victoza (liraglutide) are approved for diabetes. But Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) are for obesity.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote